| Dr Adeel Rahim Seyal, MD | |
|
2520 Cherry Ave, Bremerton, WA 98310-4229 | |
| (360) 377-3911 | |
| Not Available |
| Full Name | Dr Adeel Rahim Seyal |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 20 Years |
| Location | 2520 Cherry Ave, Bremerton, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023225406 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beth Israel Deaconess Medical Center | Boston, MA | Hospital |
| Beth Israel Deaconess Hospital - Needham | Needham, MA | Hospital |
| St Elizabeth's Medical Center | Brighton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward Medical Group Inc | 2860688728 | 1404 |
| Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc | 4486567104 | 1344 |
News Archive
Canadian maple syrup provides a pure energy source for endurance athletes and can help fight inflammation, according to new research published today.
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
A team from the Spanish National Cancer Research Centre (CNIO) has optimized a system capable of generating a cellular model of Ewing sarcoma.
Activating a mother's immune system during her pregnancy disrupts the development of neural cells in the brain of her offspring and damages the cells' ability to transmit signals and communicate with one another, researchers with the UC Davis Center for Neuroscience and Department of Neurology have found.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
› Verified 8 days ago
| Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275574899 PECOS PAC ID: 4486567104 Enrollment ID: O20040323000584 |
News Archive
Canadian maple syrup provides a pure energy source for endurance athletes and can help fight inflammation, according to new research published today.
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
A team from the Spanish National Cancer Research Centre (CNIO) has optimized a system capable of generating a cellular model of Ewing sarcoma.
Activating a mother's immune system during her pregnancy disrupts the development of neural cells in the brain of her offspring and damages the cells' ability to transmit signals and communicate with one another, researchers with the UC Davis Center for Neuroscience and Department of Neurology have found.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
› Verified 8 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356654495 PECOS PAC ID: 2860688728 Enrollment ID: O20101120000012 |
News Archive
Canadian maple syrup provides a pure energy source for endurance athletes and can help fight inflammation, according to new research published today.
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
A team from the Spanish National Cancer Research Centre (CNIO) has optimized a system capable of generating a cellular model of Ewing sarcoma.
Activating a mother's immune system during her pregnancy disrupts the development of neural cells in the brain of her offspring and damages the cells' ability to transmit signals and communicate with one another, researchers with the UC Davis Center for Neuroscience and Department of Neurology have found.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
› Verified 8 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821349317 PECOS PAC ID: 2860688728 Enrollment ID: O20130626000396 |
News Archive
Canadian maple syrup provides a pure energy source for endurance athletes and can help fight inflammation, according to new research published today.
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
A team from the Spanish National Cancer Research Centre (CNIO) has optimized a system capable of generating a cellular model of Ewing sarcoma.
Activating a mother's immune system during her pregnancy disrupts the development of neural cells in the brain of her offspring and damages the cells' ability to transmit signals and communicate with one another, researchers with the UC Davis Center for Neuroscience and Department of Neurology have found.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
› Verified 8 days ago
| Entity Name | Associated Physicians Of Harvard Medical Faculty Physicians At Beth Is |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1245773308 PECOS PAC ID: 6305749987 Enrollment ID: O20170628003015 |
News Archive
Canadian maple syrup provides a pure energy source for endurance athletes and can help fight inflammation, according to new research published today.
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
A team from the Spanish National Cancer Research Centre (CNIO) has optimized a system capable of generating a cellular model of Ewing sarcoma.
Activating a mother's immune system during her pregnancy disrupts the development of neural cells in the brain of her offspring and damages the cells' ability to transmit signals and communicate with one another, researchers with the UC Davis Center for Neuroscience and Department of Neurology have found.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adeel Rahim Seyal, MD 5702 N 33rd St, Unit 23a, Tacoma, WA 98407-2500 Ph: (253) 203-6519 | Dr Adeel Rahim Seyal, MD 2520 Cherry Ave, Bremerton, WA 98310-4229 Ph: (360) 377-3911 |
News Archive
Canadian maple syrup provides a pure energy source for endurance athletes and can help fight inflammation, according to new research published today.
Seattle Genetics, Inc. today announced that the Oncologic Drugs Advisory Committee (ODAC) to the U.S. Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of ADCETRIS™ (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
A team from the Spanish National Cancer Research Centre (CNIO) has optimized a system capable of generating a cellular model of Ewing sarcoma.
Activating a mother's immune system during her pregnancy disrupts the development of neural cells in the brain of her offspring and damages the cells' ability to transmit signals and communicate with one another, researchers with the UC Davis Center for Neuroscience and Department of Neurology have found.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma.
› Verified 8 days ago
Dr. Alanna Lauren Sandack, D.O. Radiology Medicare: Medicare Enrolled Practice Location: 1520 Ne Riddell Rd Ste 110, Bremerton, WA 98310 Phone: 360-228-7246 | |
Dr. John Walter Crowley Iii, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4426 Fax: 360-475-4344 | |
Dr. Colleen Parker, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4220 | |
Mr. James Jeffrey Rohlfing, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2700 Clare Ave, Bremerton, WA 98310 Phone: 360-479-6555 Fax: 360-479-8327 | |
Terry Chun, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2512 Wheaton Way, Bremerton, WA 98310 Phone: 360-782-3650 | |
Stephen Charles Springate, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2520 Cherry Ave, S Charles Springate Md, Bremerton, WA 98310 Phone: 360-475-8545 Fax: 360-475-8542 | |
Dr. Matthew Paul Perron Bauer, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4220 |